FDA 21 CFR Part 11
A leading global clinical research organization (CRO) aimed to conduct Risk Evaluation and Mitigation Strategy (REMS) surveys—an essential process for ensuring the safe use of medications with serious risks. However, they faced challenges in finding a reliable partner with the expertise to navigate the specific REMS survey requirements while ensuring compliance with 21 CFR Part 11 and maintaining the highest levels of data protection. The CRO required a cost-effective, flexible, and scalable solution that met FDA regulations and allowed for expedited setup.
Read More: https://www.dacimasoftware...
A leading global clinical research organization (CRO) aimed to conduct Risk Evaluation and Mitigation Strategy (REMS) surveys—an essential process for ensuring the safe use of medications with serious risks. However, they faced challenges in finding a reliable partner with the expertise to navigate the specific REMS survey requirements while ensuring compliance with 21 CFR Part 11 and maintaining the highest levels of data protection. The CRO required a cost-effective, flexible, and scalable solution that met FDA regulations and allowed for expedited setup.
Read More: https://www.dacimasoftware...
07:32 AM - May 23, 2025 (UTC)
(E)
No replys yet!
It seems that this publication does not yet have any comments. In order to respond to this publication from Dacima Software, click on at the bottom under it
Who to follow